Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis

被引:399
作者
Rodig, N
Ryan, T
Allen, JA
Pang, H
Grabie, N
Chernova, T
Greenfield, EA
Liang, SC
Sharpe, AH
Lichtman, AH
Freeman, GJ
机构
[1] Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA
关键词
T lymphocytes; endothelial cells; costimulation;
D O I
10.1002/eji.200324270
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interactions between CD8(+) T cells and endothelial cells are important in both protective and pathologic immune responses. Endothelial cells regulate the recruitment of CD8(+) T cells into tissues, and the activation of CD8+ T cells by antigen presentation and costimulatory signals. PD-L1 and PD-L2 are recently described B7-family molecules which bind to PD-1 on activated lymphocytes and down-regulate T cell activation. We found that PD-L1 is expressed on interferon-gamma stimulated cultured human and mouse endothelial cells, while PD-L2 was found on stimulated human but not mouse endothelial cells. Expression was further upregulated by TNF-alpha. Antibody blockade of endothelial cell PD-L1 and PD-L2 enhanced endothelial cell costimulation of PHA-activated human CD8(+) T cells. Antibody blockade of mouse endothelial cell PD-L1 enhanced both IFN-gamma secretion and cytolytic activity of CD8(+) T cells in response to endothelial cell antigen presentation. These results show that IFN-gamma activated endothelial cells can inhibit T cell activation via expression of the immunoinhibitory PD-L1 and PD-L2 molecules. Endothelial expression of PD-ligands would allow activation and extravasation of T cells without excessive vessel damage. Our findings highlight a potentially important pathway by which endothelial cells down-regulate CD8(+) T cell-mediated immune responses.
引用
收藏
页码:3117 / 3126
页数:10
相关论文
共 42 条
  • [1] Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: Attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses
    Bennett, F
    Luxenberg, D
    Ling, V
    Wang, IM
    Marquette, K
    Lowe, D
    Khan, N
    Veldman, G
    Jacobs, KA
    Valge-Archer, VE
    Collins, M
    Carreno, BM
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (02) : 711 - 718
  • [2] Biedermann BC, 1998, J IMMUNOL, V161, P4679
  • [3] Briscoe DM, 1997, KIDNEY INT, pS22
  • [4] Briscoe DM, 1997, J IMMUNOL, V159, P3247
  • [5] Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production
    Brown, JA
    Dorfman, DM
    Ma, FR
    Sullivan, EL
    Munoz, O
    Wood, CR
    Greenfield, EA
    Freeman, GJ
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (03) : 1257 - 1266
  • [6] INDUCTION OF OVALBUMIN-SPECIFIC CYTO-TOXIC T-CELLS BY INVIVO PEPTIDE IMMUNIZATION
    CARBONE, FR
    BEVAN, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (03) : 603 - 612
  • [7] CARBONE FR, 1994, CELL, V76, P17
  • [8] The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses
    Carreno, BM
    Collins, M
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 : 29 - 53
  • [9] Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype
    Dengler, TJ
    Pober, JS
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (10) : 5146 - 5155
  • [10] Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
    Dong, HD
    Strome, SE
    Matteson, EL
    Moder, KG
    Flies, DB
    Zhu, GF
    Tamura, H
    Driscoll, CLW
    Chen, LP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (03) : 363 - 370